Generic Name: Imfinzi (durvalumab)
Imfinzi Reviews
For Non Small Cell Lung Cancer "Cancer in remission just before 10th treatment. Many skin problems. Dry, cracking skin on sides and bottom of feet. Dry skin on arms and legs. Occasional mild headaches, terrible problems sleeping at night. All problems on mild side."
For Small Cell Lung Cancer "3 to 4 days after I have a tightness in my chest, it does go away, I also have a rash on both arms. I have constipation. Now I am having trouble swallowing, the only thing I can swallow without difficulty is soft foods and liquids. I have to go and get an X-ray of my esophagus in September. Good news is the tumor continues to shrink. I just had a CT scan with contrast a couple of weeks ago. I do have to have a CT scan every 3 months. I believe Imfinzi is helping me."
For Hepatocellular Carcinoma "Have had two infusions, and so far, so good—no side effects except feeling tired on the second day after infusion. Other than that one day, I feel fine. I have my next MRI in October to check for more cancer. Hopefully, Imfinzi is working, and I will have no return spots. Time will tell."
For Non Small Cell Lung Cancer "Had 12 treatments after completion of chemoradiation. Medication was well tolerated with minimal side effects."
More about Imfinzi (durvalumab)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: anti-PD-1 and PD-L1 monoclonal antibodies (immune checkpoint inhibitors)
- Breastfeeding
- En español
Patient resources
- Imfinzi drug information
Professional resources
- Imfinzi prescribing information
- Durvalumab (AHFS Monograph)
Related treatment guides
- Biliary Tract Tumor
- Non Small Cell Lung Cancer
- Endometrial Cancer
- Small Cell Lung Cancer
- Hepatocellular Carcinoma
